Direct-to-Consumer Genetic Testing Market worth USD 5,573.5 million by 2030

The Market Statsville Group (MSG) publishes the new report on the "Direct-to-Consumer Genetic Testing Market by Technology (Single Nucleotide Polymorphism, Targeted Analysis, and Whole Genome Sequencing), by Distribution Channel (Online Channel and OTC Channel), by Product Type (Ancestry, Health and Wellness, and Entertainment), by Region – Global Share and Forecast to 2030". The global direct-to-consumer genetic testing market size is expected to grow from USD 1,338.6 million in 2021 to USD 5,573.5 million by 2030, at a CAGR of 17.6% during the forecast period. The growing awareness about precision medicine and biologics and their increasing adoption by patients have resulted in the rising prominence of personalized treatments. Acknowledgment of the fact that all patients do not experience the same biological mechanism, despite being diagnosed with the same disease, has increased the demand for personalized treatments and, in turn, propelled the growth of its various application segment, including applied sciences research, diagnostics, therapy selection, and treatment monitoring. For instance, the gaining popularity of genomics analysis and increasing adoption of personalized medicines, owing to the use of patients' genomic information to provide targeted therapy, further helps healthcare professionals direct clinical decision-making.

Global Direct-to-Consumer Genetic Testing Market Segmentation

The direct-to-consumer genetic testing market has been segmented into technology, distribution channel, product type, and region.

• By Technology (Single Nucleotide Polymorphism, Targeted Analysis, and Whole Genome Sequencing)
• By Distribution Channel (Online Channel and OTC Channel)
• By Product Type (Ancestry, Health and Wellness, and Entertainment)
• By Region (US, Canada, Mexico, UK, Germany, France, Italy, Spain, China, Japan, India, South Korea, Southeast Asia, Australia, Saudi Arabia, UAE, South Africa, Qatar, Nigeria, Israel, Brazil, Argentina, Peru)

Ancestry, by product type, is estimated to hold the largest market share during the forecast period

The global direct-to-consumer genetic testing market is divided into three categories based on product type: ancestry, health and wellness, and entertainment. The ancestry segment generated the highest revenue and had a market share of 44.6% of the global direct-to-consumer genetic testing in 2021, and it is estimated to register a significant CAGR from 2022 to 2030. Ancestry testing, also known as genealogy testing, is a form of direct-to-consumer genetic testing that reveals information regarding a person’s ancestry relationship, both for the paternal and maternal sides. Also, ancestry tests help discover the individual’s ancient origin by going back as far as hundreds of thousands of years. It helps to explore the ancestral origins—where an individual’s DNA falls among several specific regional ancestry clusters.

DNA family, which can be determined using these ancestry tests, helps to understand how an individual is connected to other populations of the world by tracing the heritage through the centuries and tracing the clues of when and where the ancestors lived. These tests help to understand the unique traits that a person may have inherited from Neanderthal ancestors, such as muscle growth, skin color, and cognitive ability.

Don't miss out on business opportunities in Direct-to-Consumer Genetic Testing Market. Speak to our research analyst and gain crucial market insights that will benefit your business grow.

North America accounts for the largest market share in the direct-to-consumer genetic testing market in 2021

Based on the regions, the global direct-to-consumer genetic testing market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America had the largest market revenue with a market share of 46.4%. The growth can be attributed to the availability of a large number of key players, the high adoption rate for advanced technologies, increasing healthcare infrastructure, and faster product approvals by the regulatory bodies in the region. The development of novel genetic tests that could predict potential allergies, different responses of medication, and associated risks of genetic diseases such as neurofibromatosis, cancer, and spinal muscular atrophy is another factor supporting the growth of the target market in North America.

Easy availability of different types of DT tests specific to the disease type and transition of vaccines from trivalent to quadrivalent formulations, owing to extensive research and development by manufacturers to offer prediction and detection against infectious diseases, are major factors augmenting the growth of the direct-to-consumer genetic testing market in the U.S. In addition, the emerging technological advancements in the sequencing process, proper execution of the Human Genome Project, and novel DTC-GT that can provide information both on health and ancestry origins have remarkably revolutionized the direct-to-consumer genetic testing industry.

This research report includes a study on the development and marketing strategies, along with a study on the product portfolios and winning strategies of the leading companies operating in the direct-to-consumer genetic testing market. It also consists of leading companies such as 23andme, Color Health, Inc., My heritage, Myriad Genetics, Konica Minolta, Inc., Atlas Biomed, Ancestry.com LL, EasyDNA, DNA fit, Gene by Gene, XCode Life, Mapmygenome, and 23mofang.

Browse complete report: https://www.marketstatsville.com/direct-to-consumer-genetic-testing-market

About Market Statsville Group

Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.

MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.

Contact Us:

Market Statsville Group

416, East Standsberry Street, Perkins, Oklahoma 74059, USA

USA: +1-580-205-2707 | +91 702 496 8807

Email: sales@marketstatsville.com

Web: www.marketstatsville.com